Cargando…

A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer

PURPOSE: To characterize programmed cell death ligand-1 (PD-L1) expression in relation to survival and gene mutation status in patients with advanced NSCLC. The study also explored the influence of tumor mutational burden (TMB) on PD-L1 expression and patient characteristics. PATIENTS AND METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schabath, Matthew B, Dalvi, Tapashi B, Dai, Hongyue A, Crim, Alan L, Midha, Anita, Shire, Norah, Gimbrone, Nicholas T, Walker, Jill, Greenawalt, Danielle M, Lawrence, David, Rigas, James R, Brody, Robert, Potter, Danielle, Kumar, Naveen S, Huntsman, Shane A, Gray, Jhanelle E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844199/ https://www.ncbi.nlm.nih.gov/pubmed/31819612 http://dx.doi.org/10.2147/CMAR.S218635

Ejemplares similares

Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark
por: Dalvi, Tapashi, et al.
Publicado: (2023)

PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study
por: Cronin-Fenton, Deirdre, et al.
Publicado: (2021)

Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images
por: Mu, Wei, et al.
Publicado: (2021)

Qualitative Findings From a Survey on Patient Experiences and Satisfaction with Lung Cancer Screening
por: Pérez-Morales, Jaileene, et al.
Publicado: (2023)

Hypoxia-Related Radiomics and Immunotherapy Response: A Multicohort Study of Non-Small Cell Lung Cancer
por: Tunali, Ilke, et al.
Publicado: (2021)

Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer
por: Manjarrez-Orduño, Nataly, et al.
Publicado: (2018)

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer
por: Puri, Sonam, et al.
Publicado: (2020)

Magnitude of Stratification in Human Populations and Impacts on Genome Wide Association Studies
por: Hao, Ke, et al.
Publicado: (2010)

HUMAN VASCULAR ENDOTHELIAL CELLS IN CULTURE : Growth and DNA Synthesis
por: Gimbrone, Michael A., et al.
Publicado: (1974)

Plasma Cell‐Free DNA Genotyping: From an Emerging Concept to a Standard‐of‐Care Tool in Metastatic Non‐Small Cell Lung Cancer
por: Gray, Jhanelle, et al.
Publicado: (2021)

Conquering the Synthesis and Functionalization of Bicyclo[1.1.1]pentanes
por: Shire, Bethany R., et al.
Publicado: (2023)

Non-invasive decision support for NSCLC treatment using PET/CT radiomics
por: Mu, Wei, et al.
Publicado: (2020)

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study
por: O’Shaughnessy, Joyce, et al.
Publicado: (2020)

Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies
por: O'Shannessy, Daniel J., et al.
Publicado: (2016)

Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study
por: Block, Gladys, et al.
Publicado: (2007)

Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival
por: Beebe-Dimmer, Jennifer L, et al.
Publicado: (2016)

STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world
por: Shire, Norah J., et al.
Publicado: (2020)

Clinical associations of mucin 1 in human lung cancer and precancerous lesions
por: Saltos, Andreas, et al.
Publicado: (2018)

Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma
por: Rebelatto, Marlon C., et al.
Publicado: (2016)

Impact of COVID-19 Pandemic on Frontline Pembrolizumab-Based Treatment for Advanced Lung Cancer
por: Tanvetyanon, Tawee, et al.
Publicado: (2023)

Bioinformatic Methods and Bridging of Assay Results for Reliable Tumor Mutational Burden Assessment in Non-Small-Cell Lung Cancer
por: Chang, Han, et al.
Publicado: (2019)

Association between immune-mediated adverse events and efficacy in metastatic non-small-cell lung cancer patients treated with durvalumab and tremelimumab
por: Dey, Agnish, et al.
Publicado: (2022)

TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION
por: Gimbrone, Michael A., et al.
Publicado: (1972)

1-Bromomethyl-4-aza-1-azoniabicyclo[2.2.2]octane bromide
por: Finke, Aaron D., et al.
Publicado: (2010)

Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistance
por: Creelan, Ben C., et al.
Publicado: (2019)

5-Hydroxy-3-methyl-5-phenyl-4,5-dihydro-1H-pyrazole-1-carbothioamide
por: Ganguly, Biplab, et al.
Publicado: (2011)

Ras interacting protein 1 facilitated proliferation and invasion of diffuse large B-cell lymphoma cells
por: Xing, Xiaojing, et al.
Publicado: (2023)

Co-Evolution of Somatic Variation in Primary and Metastatic Colorectal Cancer May Expand Biopsy Indications in the Molecular Era
por: Kim, Richard, et al.
Publicado: (2015)

Targeting Trop-2 in solid tumors: future prospects
por: Zaman, Saif, et al.
Publicado: (2019)

Defining the Akt1 interactome and its role in regulating the cell cycle
por: Duggal, Shweta, et al.
Publicado: (2018)

Hepatitis E Virus Antibodies in Patients with Chronic Liver Disease
por: Atiq, Muslim, et al.
Publicado: (2009)

Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy
por: Chen, Dung-Tsa, et al.
Publicado: (2023)

1,1,2,2-Tetrakis(di-o-tolylphosphino)ethane
por: Sisler, Elizabeth M., et al.
Publicado: (2009)

TYPO3 Templates
por: Greenawalt, Jeremy
Publicado: (2010)

Macrophage Inhibitory Factor-1 (MIF-1) controls the plasticity of multiple myeloma tumor cells
por: Joseph, Danielle, et al.
Publicado: (2018)

Cell contact interactions in rheumatology, The Kennedy Institute for Rheumatology, London, UK, 1-2 June 2000
por: Burger, Danielle
Publicado: (2000)

Dissecting Cis Regulation of Gene Expression in Human Metabolic Tissues
por: Dobrin, Radu, et al.
Publicado: (2011)

Both aldosterone and spironolactone can modulate the intracellular ACE/ANG II/AT1 and ACE2/ANG (1‐7)/MAS receptor axes in human mesangial cells
por: Stoll, Danielle, et al.
Publicado: (2019)

Biomarkers of therapeutic response with immune checkpoint inhibitors
por: Bindal, Poorva, et al.
Publicado: (2021)

Defining the Akt1 interactome data and delineating alterations in its composition as a function of cell cycle progression
por: Duggal, Shweta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n5047r7md1v5qnq1h80ogo3ffi